199 related articles for article (PubMed ID: 19087299)
1. Does the drug sensitivity of malaria parasites depend on their virulence?
Schneider P; Chan BH; Reece SE; Read AF
Malar J; 2008 Dec; 7():257. PubMed ID: 19087299
[TBL] [Abstract][Full Text] [Related]
2. Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi.
Schneider P; Bell AS; Sim DG; O'Donnell AJ; Blanford S; Paaijmans KP; Read AF; Reece SE
Proc Biol Sci; 2012 Nov; 279(1747):4677-85. PubMed ID: 23015626
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis.
Buckling A; Crooks L; Read A
Exp Parasitol; 1999 Sep; 93(1):45-54. PubMed ID: 10464038
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD
Malar J; 2010 May; 9():135. PubMed ID: 20492669
[TBL] [Abstract][Full Text] [Related]
5. Fitness of drug-resistant malaria parasites.
Walliker D; Hunt P; Babiker H
Acta Trop; 2005 Jun; 94(3):251-9. PubMed ID: 15845348
[TBL] [Abstract][Full Text] [Related]
6. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.
de Roode JC; Culleton R; Bell AS; Read AF
Malar J; 2004 Sep; 3():33. PubMed ID: 15367331
[TBL] [Abstract][Full Text] [Related]
7. Virulence in rodent malaria: host genotype by parasite genotype interactions.
Mackinnon MJ; Gaffney DJ; Read AF
Infect Genet Evol; 2002 Jul; 1(4):287-96. PubMed ID: 12798007
[TBL] [Abstract][Full Text] [Related]
8. Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites.
Pollitt LC; Huijben S; Sim DG; Salathé RM; Jones MJ; Read AF
PLoS Pathog; 2014 Apr; 10(4):e1004019. PubMed ID: 24763470
[TBL] [Abstract][Full Text] [Related]
9. On the contribution of the rodent model Plasmodium chabaudi for understanding the genetics of drug resistance in malaria.
Cravo P
Parasitol Int; 2022 Dec; 91():102623. PubMed ID: 35803536
[TBL] [Abstract][Full Text] [Related]
10. Aggressive chemotherapy and the selection of drug resistant pathogens.
Huijben S; Bell AS; Sim DG; Tomasello D; Mideo N; Day T; Read AF
PLoS Pathog; 2013 Sep; 9(9):e1003578. PubMed ID: 24068922
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria.
Bell AS; Huijben S; Paaijmans KP; Sim DG; Chan BH; Nelson WA; Read AF
PLoS One; 2012; 7(6):e37172. PubMed ID: 22701563
[TBL] [Abstract][Full Text] [Related]
12. A high-coverage artificial chromosome library for the genome-wide screening of drug-resistance genes in malaria parasites.
Iwanaga S; Kaneko I; Yuda M
Genome Res; 2012 May; 22(5):985-92. PubMed ID: 22426943
[TBL] [Abstract][Full Text] [Related]
13. Virulence and drug resistance in malaria parasites.
Stein WD; Sanchez CP; Lanzer M
Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
[TBL] [Abstract][Full Text] [Related]
14. The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.
Huijben S; Sim DG; Nelson WA; Read AF
J Evol Biol; 2011 Nov; 24(11):2410-22. PubMed ID: 21883612
[TBL] [Abstract][Full Text] [Related]
15. Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.
Huijben S; Chan BH; Read AF
Am J Trop Med Hyg; 2015 Jun; 92(6):1214-21. PubMed ID: 25940195
[TBL] [Abstract][Full Text] [Related]
16. Host heterogeneity is a determinant of competitive exclusion or coexistence in genetically diverse malaria infections.
de Roode JC; Culleton R; Cheesman SJ; Carter R; Read AF
Proc Biol Sci; 2004 May; 271(1543):1073-80. PubMed ID: 15293862
[TBL] [Abstract][Full Text] [Related]
17. Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites.
Hunt P; Martinelli A; Modrzynska K; Borges S; Creasey A; Rodrigues L; Beraldi D; Loewe L; Fawcett R; Kumar S; Thomson M; Trivedi U; Otto TD; Pain A; Blaxter M; Cravo P
BMC Genomics; 2010 Sep; 11():499. PubMed ID: 20846421
[TBL] [Abstract][Full Text] [Related]
18. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria.
Méndez F; Muñoz A; Carrasquilla G; Jurado D; Arévalo-Herrera M; Cortese JF; Plowe CV
Am J Epidemiol; 2002 Aug; 156(3):230-8. PubMed ID: 12142257
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.
Huijben S; Nelson WA; Wargo AR; Sim DG; Drew DR; Read AF
Evolution; 2010 Oct; 64(10):2952-68. PubMed ID: 20584075
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
